Search Orphan Drug Designations and Approvals
-
| Generic Name: | recombinant human IgG1 neutralizing monoclonal antibody (mAb) that recognizes the dengue virus (DENV) envelope (E) protein |
|---|---|
| Date Designated: | 06/21/2023 |
| Orphan Designation: | Treatment of dengue |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
AbViro LLC 4800 Hampden Lane, Suite 200 Bethesda, Maryland 20814 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







